PL376122A1 - Sposób wytwarzania rekombinowanej szczepionki przeciwko krwotocznej chorobie królików, szczepionka oraz zastosowanie antygenu rekombinowanego białka do wytwarzania szczepionki - Google Patents

Sposób wytwarzania rekombinowanej szczepionki przeciwko krwotocznej chorobie królików, szczepionka oraz zastosowanie antygenu rekombinowanego białka do wytwarzania szczepionki

Info

Publication number
PL376122A1
PL376122A1 PL376122A PL37612205A PL376122A1 PL 376122 A1 PL376122 A1 PL 376122A1 PL 376122 A PL376122 A PL 376122A PL 37612205 A PL37612205 A PL 37612205A PL 376122 A1 PL376122 A1 PL 376122A1
Authority
PL
Poland
Prior art keywords
vaccine
manufacture
recombined
application
protein gene
Prior art date
Application number
PL376122A
Other languages
English (en)
Other versions
PL205229B1 (pl
Inventor
Andrzej Fitzner
Andrzej Kesy
Boguslaw Szewczyk
Beata Gromadzka
Original Assignee
Panstwowy Inst Weterynaryjny P
Univ Gdanski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panstwowy Inst Weterynaryjny P, Univ Gdanski filed Critical Panstwowy Inst Weterynaryjny P
Priority to PL376122A priority Critical patent/PL205229B1/pl
Priority to EP06769511A priority patent/EP1904098A2/en
Priority to PCT/PL2006/000047 priority patent/WO2007008093A2/en
Publication of PL376122A1 publication Critical patent/PL376122A1/pl
Publication of PL205229B1 publication Critical patent/PL205229B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
PL376122A 2005-07-08 2005-07-08 Sposób wytwarzania rekombinowanej szczepionki przeciwko krwotocznej chorobie królików, szczepionka oraz zastosowanie antygenu rekombinowanego białka do wytwarzania szczepionki PL205229B1 (pl)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL376122A PL205229B1 (pl) 2005-07-08 2005-07-08 Sposób wytwarzania rekombinowanej szczepionki przeciwko krwotocznej chorobie królików, szczepionka oraz zastosowanie antygenu rekombinowanego białka do wytwarzania szczepionki
EP06769511A EP1904098A2 (en) 2005-07-08 2006-07-06 A method of manufacturing a recombinant vaccine against viral rabbit haemorrhagic disease, the vaccine, the application of a recombinant antigen in the manufacture of the vaccine
PCT/PL2006/000047 WO2007008093A2 (en) 2005-07-08 2006-07-06 A method of manufacturing a recombinant vaccine against viral rabbit haemorrhagic disease, the vaccine, the application of a recombinant antigen in the manufacture of the vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL376122A PL205229B1 (pl) 2005-07-08 2005-07-08 Sposób wytwarzania rekombinowanej szczepionki przeciwko krwotocznej chorobie królików, szczepionka oraz zastosowanie antygenu rekombinowanego białka do wytwarzania szczepionki

Publications (2)

Publication Number Publication Date
PL376122A1 true PL376122A1 (pl) 2007-01-22
PL205229B1 PL205229B1 (pl) 2010-03-31

Family

ID=37562591

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376122A PL205229B1 (pl) 2005-07-08 2005-07-08 Sposób wytwarzania rekombinowanej szczepionki przeciwko krwotocznej chorobie królików, szczepionka oraz zastosowanie antygenu rekombinowanego białka do wytwarzania szczepionki

Country Status (3)

Country Link
EP (1) EP1904098A2 (pl)
PL (1) PL205229B1 (pl)
WO (1) WO2007008093A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019195938A1 (en) * 2018-04-11 2019-10-17 Luminultra Technologies Ltd. Methods and kits for nucleic acid purification and other procedures
CN112480269A (zh) * 2020-12-11 2021-03-12 杭州爱谨生物科技有限公司 一种兔病毒性出血症病毒vp10-vp60重组蛋白及其制备方法和应用
US12503493B2 (en) * 2021-08-05 2025-12-23 Vst Llc Rabbit haemorrhagic disease virus (RHDV) vaccines
CN115444933B (zh) * 2022-09-14 2023-08-29 贵州福斯特生物科技有限公司 一种兔用水溶性复合佐剂的制备方法及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2080023B1 (es) * 1994-07-08 1996-08-16 Iberica Cyanamid Capsidas y proteinas recombinantes del virus de la enfermedad hemorragica del conejo (rhdv), kits de diagnostico y vacunas que contienen dichos productos recombinantes.

Also Published As

Publication number Publication date
WO2007008093A3 (en) 2007-04-19
PL205229B1 (pl) 2010-03-31
EP1904098A2 (en) 2008-04-02
WO2007008093A2 (en) 2007-01-18

Similar Documents

Publication Publication Date Title
EG25848A (en) Systems and methods for protein production
ZA200703561B (en) Methods and compositions for improving recombinant protein production
IL179140A0 (en) Antibody drug conjuates and methods
EP1856291A4 (en) NUCLEIC ACIDS AND PROTEINS, AND METHODS OF MAKING AND USING SAME
EP1912667A4 (en) CONCENTRATED PROTEIN LYOPHILISATES, ASSOCIATED METHODS AND USES THEREOF
IL182837A0 (en) Methods, assays and compositions for treating retinol-related diseases
SG10201600950TA (en) Recombinant monovalent antibodies and methods for production thereof
IL181278A0 (en) Systems and methods for protein production
EP1901820A4 (en) PROCESS FOR REDUCING THE CONDITION OF PROTEINS RELATED TO DISEASES
DK1768833T3 (da) Formlegeme, fremgangsmåde til dets fremstilling samt dets anvendelse
EP1766073A4 (en) IMPROVING PROTEIN EXPRESSION
EP1922086A4 (en) TARGETED PROTEIN KINASE C HEMMER AND ITS USES
EP1731139A4 (en) PHARMACEUTICAL PREPARATION OF THE S / O TYPE AND MANUFACTURING METHOD THEREFOR
PL376122A1 (pl) Sposób wytwarzania rekombinowanej szczepionki przeciwko krwotocznej chorobie królików, szczepionka oraz zastosowanie antygenu rekombinowanego białka do wytwarzania szczepionki
EP1757303A4 (en) DRUGS USING HUMAN LYSOZYM, THE PRODUCTION METHOD AND THE APPLICATION
EP1805210A4 (en) NOVEL PEPTIDES AND METHODS FOR THE TREATMENT OF INFLAMMATORY DISEASE
WO2006020430A8 (en) Novel composition and methods for the treatment of immune related disease
EP1922328A4 (en) PEPTIDES TARGETED ON C PROTEIN KINASE ISOFORMS AND USE THEREOF
ZA200804337B (en) Recombinant monovalent antibodies and methods for production thereof
EP1760149A4 (en) PROCESS FOR CONSTRUCTING MODIFIED PROTEIN
ITPD20050075A1 (it) Procedimento per la realizzazione di decori almeno in parte bispecchiati e prodotto ottenuto
GB0404929D0 (en) Protein
GB0401882D0 (en) Protein
GB0411255D0 (en) Method of protein amplification
HK1101678A (en) Compositions and methods for protein production